Long Term Study To Evaluate the Safety, Tolerability and Efficacy of Fesoterodine for Overactive Bladder.

Clinical trial NCT00658684 · COMPLETED

Trial details

NCT number: NCT00658684
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Overactive Bladder

Start date: 2008-02-01
Primary completion: 2009-08-01
Enrollment: 153

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.